5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 16.81▲ | 16.81▲ | 16.72▲ | 15.49▲ | 15.10▲ |
MA10 | 16.78▲ | 16.64▲ | 16.40▲ | 15.15▲ | 14.53▲ |
MA20 | 16.78▲ | 16.38▲ | 15.97▲ | 14.93▲ | 14.23▲ |
MA50 | 16.67▲ | 15.61▲ | 15.04▲ | 14.49▲ | 13.00▲ |
MA100 | 16.43▲ | 15.04▲ | 14.89▲ | 14.39▲ | 10.00▲ |
MA200 | 15.99▲ | 14.90▲ | 14.91▲ | 13.63▲ | 13.22▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.012▲ | 0.080▲ | 0.167▲ | 0.116▲ |
RSI | 67.081▲ | 69.769▲ | 77.747▲ | 66.007▲ | 62.811▲ |
STOCH | 72.149 | 94.803▲ | 87.528▲ | 58.833 | 69.447 |
WILL %R | -7.143▲ | -1.471▲ | -0.923▲ | -0.622▲ | -0.477▲ |
CCI | 256.551▲ | 98.927 | 109.132▲ | 229.165▲ | 198.961▲ |
Friday, August 08, 2025 01:13 PM
Arcutis is providing this information in accordance with Nasdaq Listing Rule 5635 (c) (4).
|
Friday, August 08, 2025 05:33 AM
Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good day, and thank you for standing by. Welcome to the Arcutis Biotherapeutics 2025 Second Quarter Financial Results Conference Call.
|
Thursday, August 07, 2025 12:06 AM
Key Points Revenue (GAAP) soared 164% year over year to $81.5 million, surpassing analyst estimates by $7.81 million (GAAP). Net loss per share (GAAP) improved sharply to $(0.13), beating expectations ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 16.11 | 16.91 | 16.08 | 16.89 | 2,009,532 |
14/08/25 | 15.21 | 16.14 | 15.14 | 15.98 | 2,475,782 |
13/08/25 | 14.97 | 15.885 | 14.80 | 15.63 | 2,927,628 |
12/08/25 | 14.22 | 14.83 | 14.08 | 14.74 | 1,471,467 |
11/08/25 | 14.52 | 14.625 | 14.03 | 14.19 | 1,624,130 |
08/08/25 | 14.03 | 14.795 | 13.695 | 14.77 | 2,613,468 |
07/08/25 | 16.27 | 16.39 | 13.735 | 14.12 | 4,360,755 |
06/08/25 | 15.05 | 15.68 | 14.76 | 15.36 | 1,918,947 |
05/08/25 | 14.51 | 15.34 | 14.37 | 15.325 | 1,845,449 |
04/08/25 | 14.29 | 14.68 | 13.965 | 14.52 | 1,261,146 |
|
|
||||
|
|
||||
|
|